Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rua Bioscience Limited Share Issue/Capital Change 2023

Jun 30, 2023

66262_rns_2023-06-30_852fe615-b745-4165-b3d0-f90ac435b6f1.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [101 x 49] intentionally omitted <==

Capital Change Notice

Updated as at 17 October 2019

Section 1: Issuer information Section 1: Issuer information Section 1: Issuer information Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of financial product Ordinary Shares
ISIN (If unknown, check on NZX website) NZRUAE0004S1
Currency NZD
Section 2: Capital change details
Number issue~~d~~ ~~/acquired/redeemed~~ 116,998
Nominal value (if any) Nil
Issu~~e~~ ~~/acquisition/redemption p~~rice per security Nil
Nature of the payment (for example, cash or other
consideration)
Zero cash – provision of
employment and personal
services to the Issuer.
Amount paid up (if not in full) N/A (as issued for no cash
consideration).
Percentage of total class of Financial Products
issue~~d/acquired/redeemed/~~(calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)1
0.074% (3dp) of the total
number of Ordinary Shares on
issue (undiluted)
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
N/A
Reason for issu~~e~~ Consideration for services and
performance incentive for
employees (part of
remuneration package)
for issu~~e~~
Total number of Financial Products of the Class after the
issu~~e/acquisition/redemption/Conversion~~(excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
158,136,265
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A
Specific authority for the issue Authority was given pursuant
to a resolution dated February
2023 and in accordance with
Listing rule 4.6.1. 4.11.1 and
5.2.2(e).

1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issu~~e, acquisition, or redemption~~(for
example: restrictions, escrow arrangements)
Terms or details of the issu~~e, acquisition, or redemption~~(for
example: restrictions, escrow arrangements)
Share are issued pursuant to a
Share Option Deed dated
February 2023. Participant is
a good leaver and will be
required to pay associated tax
liability
Date of issu~~e~~ ~~/acquisition/redemption~~2 30 June 2023
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement Paul Naske
Contact person for this announcement Paul Naske
Contact phone number 021445154
Contact email address [email protected]
Date of release through MAP 30/06/2023

2 Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).